PSA Screening: New Round Of Guidelines Emphasizes Importance Of Weighing Harms And Benefits

 For nearly a quarter century, doctors have ordered annual PSA tests for men of a certain age to screen for prostate cancer, despite a lack of evidence that the benefits outweighed the risks -- especially when tiny, slow-growing tumors were detected. But the landscape appears to be changing. While questions about PSA screening remain, physicians increasingly recognize the need to discuss both the harms and benefits with patients.

Read more: 
PSA Screening: New Round Of Guidelines Emphasizes Importance Of Weighing Harms And Benefits

Source: Kaiser Health News


Art and Science of Laboratory Medicine

Facebook: www.facebook.com/LaboratoryEQAS

Twitter: LaboratoryEQAS